- Home
- HIND vs GXAI Comparison
HIND vs GXAI Comparison
Compare HIND & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | HIND | GXAI |
|---|---|---|
| Founded | 2017 | 2021 |
| Country | United States | United States |
| Employees | 18 | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.8M | 12.3M |
| IPO Year | 2016 | 2022 |
Fundamental Metrics
Financial Performance| Metric | HIND | GXAI |
|---|---|---|
| Price | $2.22 | $1.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 19.0K | ★ 3.3M |
| Earning Date | 05-20-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 71.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,933,030.00 |
| Revenue This Year | N/A | $271.23 |
| Revenue Next Year | N/A | $36.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 47901.74 |
| 52 Week Low | $1.75 | $1.02 |
| 52 Week High | $12.87 | $2.96 |
Technical Indicators
Market Signals| Indicator | HIND | GXAI |
|---|---|---|
| Relative Strength Index (RSI) | 48.23 | 48.27 |
| Support Level | $2.02 | $1.06 |
| Resistance Level | $2.41 | $1.32 |
| Average True Range (ATR) | 0.17 | 0.14 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 21.12 | 5.00 |
Price Performance
Historical ComparisonAbout HIND Vyome Holdings Inc.
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is a technology company focused on reshaping the way people interact with artificial intelligence across everyday life and high-impact industries. It is engaged in building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. The company's portfolio spans defense, health and wellness, entertainment, and productivity - bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes. It operates as a single operating segment technology-based company that is developing applications aimed at redefining the way it utilizes artificial intelligence (AI) to optimize the user experience.